Using a mouse model of bleomycin-induced pulmonary fibrosis, we also discovered that pirfenidone inhibits HSP47 over-expression in myofibroblasts and in type II pneumocytes, especially in fibrotic lesions, and that this activity is concomitant with an obvious reduction in fibrosis [12]. This evidence concerns the gene SERPINH1 and pulmonary fibrosis.